Emerging treatment options for psoriasis

被引：3
作者：
Taheri, Arash [1 ]
Sandoval, Laura F. [1 ]
Tuchayi, Sara Moradi [1 ]
Alinia, Hossein [1 ]
Mansoori, Parisa [1 ,2 ]
Feldman, Steven R. [1 ,3 ]
机构：
[1] Wake Forest Sch Med, Ctr Dermatol Res, Dept Dermatol, Winston Salem, NC USA
[2] Wake Forest Sch Med, Dept Pathol, Winston Salem, NC USA
[3] Wake Forest Sch Med, Dept Publ Hlth Sci, Winston Salem, NC USA
来源：
PSORIASIS-TARGETS AND THERAPY | 2014年 / 4卷
关键词：
psoriasis; therapy; interleukin-17; biologics; emerging; treatment;
D O I：
10.2147/PTT.S54068
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
The treatment of psoriasis has evolved over the years, with the recent focus largely on the use of biologics and anti-interleukin-17 agents. With treatment options expanding, practitioners and patients may find control of psoriasis more convenient and safer to achieve. In this article, we review the literature on emerging medications for the treatment of psoriasis. Although some of the new medications under development, such as the anti-interleukin-17 agents, are being shown to be very efficacious in the treatment of psoriasis in premarketing trials, more information regarding their long-term use is needed to demonstrate their superiority over available modalities.
引用
收藏
页码：27 / 35
页数：9
相关论文
共 79 条
[1]   Options and Opportunities for Clinical Management and Treatment of Psoriasis [J].
Agrawal, Udita ;
Gupta, Madhu ;
Dube, Devyani ;
Vyas, Suresh P. .
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2013, 30 (01) :51-90
[2]   Studies of Jak/STAT3 expression and signalling in psoriasis identifies STAT3-Ser727 phosphorylation as a modulator of transcriptional activity [J].
Andres, Rosa M. ;
Hald, Anne ;
Johansen, Claus ;
Kragballe, Knud ;
Iversen, Lars .
EXPERIMENTAL DERMATOLOGY, 2013, 22 (05) :323-328
[3]   Targeting IL-17 in psoriasis: From cutaneous immunobiology to clinical application [J].
Ariza, Maria-Eugenia ;
Williams, Marshall V. ;
Wong, Henry K. .
CLINICAL IMMUNOLOGY, 2013, 146 (02) :131-139
[4]   Treatment goals for moderate to severe psoriasis: An Australian consensus [J].
Baker, Christopher ;
Mack, Alexandra ;
Cooper, Alan ;
Fischer, Gayle ;
Shumack, Stephen ;
Sidhu, Shireen ;
Soyer, Peter ;
Wu, Jason ;
Chan, Jonathan ;
Nash, Peter ;
Rawlin, Morton ;
Radulski, Barbara ;
Foley, Peter .
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2013, 54 (02) :148-154
[5]   Efficacy and safety of topical WBI-1001 in patients with mild to moderate psoriasis: results from a randomized double-blind placebo-controlled, phase II trial [J].
Bissonnette, R. ;
Bolduc, C. ;
Maari, C. ;
Nigen, S. ;
Webster, J. M. ;
Tang, L. ;
Lyle, M. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (12) :1516-1521
[6]   Cardiovascular Mortality in Psoriasis and Psoriatic Arthritis: Epidemiology, Pathomechanisms, Therapeutic Implications, and Perspectives [J].
Boehncke, Wolf-Henning ;
Boehncke, Sandra .
CURRENT RHEUMATOLOGY REPORTS, 2012, 14 (04) :343-348
[7]   From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited [J].
Boniface, Katia ;
Blom, Bianca ;
Liu, Yong-Jun ;
Malefyt, Rene de Waal .
IMMUNOLOGICAL REVIEWS, 2008, 226 :132-146
[8]   Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation [J].
Cai, Yihua ;
Shen, Xiaoyan ;
Ding, Chuanlin ;
Qi, Chunjian ;
Li, Kejia ;
Li, Xia ;
Jala, Venkatakrishna R. ;
Zhang, Huang-ge ;
Wang, Tian ;
Zheng, Jie ;
Yan, Jun .
IMMUNITY, 2011, 35 (04) :596-610
[9]   Serum Levels of IL-17 and IL-22 Are Reduced by Etanercept, but not by Acitretin, in Patients with Psoriasis: a Randomized-Controlled Trial [J].
Caproni, M. ;
Antiga, E. ;
Melani, L. ;
Volpi, W. ;
Del Bianco, E. ;
Fabbri, P. .
JOURNAL OF CLINICAL IMMUNOLOGY, 2009, 29 (02) :210-214
[10]   Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-α levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy [J].
Coimbra, S. ;
Oliveira, H. ;
Reis, F. ;
Belo, L. ;
Rocha, S. ;
Quintanilha, A. ;
Figueiredo, A. ;
Teixeira, F. ;
Castro, E. ;
Rocha-Pereira, P. ;
Santos-Silva, A. .
BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (06) :1282-1290
12345678